Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
Recruiting
Observational Study
Allergic Bronchopulmonary Aspergillosis (ABPA)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 140 (estimated)
- Sponsor
- Qianfoshan Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis.
* Meets the diagnostic criteria for fungal-sensitized asthma.
Exclusion Criteria:
* Human immunodeficiency virus infection.
* Malignant tumor.
* Blood system disease.
* autoimmune system disease.
* Hi…
Contacts